- Home
- WBS vs RVTY Comparison
WBS vs RVTY Comparison
Compare WBS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WBS | RVTY |
|---|---|---|
| Founded | 1935 | 1937 |
| Country | United States | United States |
| Employees | 4601 | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 9.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | WBS | RVTY |
|---|---|---|
| Price | $72.31 | $98.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 16 |
| Target Price | $73.64 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 2.7M | 1.4M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.23% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $5.32 | $6.37 |
| Revenue Next Year | $5.89 | $5.10 |
| P/E Ratio | ★ $12.28 | $284.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.66 | $81.22 |
| 52 Week High | $74.00 | $118.30 |
Technical Indicators
Market Signals| Indicator | WBS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 51.58 |
| Support Level | $71.13 | $94.04 |
| Resistance Level | $73.72 | $102.68 |
| Average True Range (ATR) | 0.63 | 3.34 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 46.17 | 40.54 |
Price Performance
Historical ComparisonAbout WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.